These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28017402)

  • 1. First Ebola virus vaccine to protect human beings?
    Geisbert TW
    Lancet; 2017 Feb; 389(10068):479-480. PubMed ID: 28017402
    [No Abstract]   [Full Text] [Related]  

  • 2. Ebola vaccine is safe and immunogenic, results show.
    Gulland A
    BMJ; 2015 Jan; 350():h524. PubMed ID: 25633684
    [No Abstract]   [Full Text] [Related]  

  • 3. Ebola vaccine success.
    Mullard A
    Nat Rev Drug Discov; 2017 Feb; 16(2):77. PubMed ID: 28148944
    [No Abstract]   [Full Text] [Related]  

  • 4. One Step Closer to an Ebola Virus Vaccine.
    Bausch DG
    N Engl J Med; 2017 Mar; 376(10):984-985. PubMed ID: 25426836
    [No Abstract]   [Full Text] [Related]  

  • 5. Approaches to demonstration of Ebola virus vaccine efficacy.
    Krause PR; Cavaleri M; Coleman G; Gruber MF
    Lancet Infect Dis; 2015 Jun; 15(6):627-9. PubMed ID: 26008825
    [No Abstract]   [Full Text] [Related]  

  • 6. Adenovirus-vectored Ebola vaccines.
    Gilbert SC
    Expert Rev Vaccines; 2015; 14(10):1347-57. PubMed ID: 26289977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A glimpse into immune responses evolving against Ebola virus.
    Saphire EO
    Nat Med; 2019 Oct; 25(10):1470-1471. PubMed ID: 31591604
    [No Abstract]   [Full Text] [Related]  

  • 8. Early trials of Ebola vaccine show immune response.
    Mayor S
    BMJ; 2015 Apr; 350():h1844. PubMed ID: 25855620
    [No Abstract]   [Full Text] [Related]  

  • 9. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the Loop.
    Mire CE; Geisbert TW
    Trends Mol Med; 2017 Aug; 23(8):669-671. PubMed ID: 28697885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Make Ebola a thing of the past': first vaccine against deadly virus approved.
    Callaway E
    Nature; 2019 Nov; 575(7783):425-426. PubMed ID: 31745354
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates.
    Wong G; Richardson JS; Pillet S; Racine T; Patel A; Soule G; Ennis J; Turner J; Qiu X; Kobinger GP
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S379-83. PubMed ID: 25957963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys.
    Lingemann M; Liu X; Surman S; Liang B; Herbert R; Hackenberg AD; Buchholz UJ; Collins PL; Munir S
    J Virol; 2017 May; 91(10):. PubMed ID: 28250127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebola Virus: Sensationalism, Science, and Human Rights.
    Bausch DG; Clougherty MM
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S79-83. PubMed ID: 26203057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of protection from Ebola virus infection.
    Krause PR; Bryant PR; Clark T; Dempsey W; Henchal E; Michael NL; Regules JA; Gruber MF
    Sci Transl Med; 2015 May; 7(286):286ps11. PubMed ID: 25947159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine.
    Zhou Y; Sullivan NJ
    Curr Opin Immunol; 2015 Aug; 35():131-6. PubMed ID: 26247875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.
    Mire CE; Matassov D; Geisbert JB; Latham TE; Agans KN; Xu R; Ota-Setlik A; Egan MA; Fenton KA; Clarke DK; Eldridge JH; Geisbert TW
    Nature; 2015 Apr; 520(7549):688-691. PubMed ID: 25853476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebola virus - prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine.
    Robinson HL; Marzi A
    Expert Rev Vaccines; 2018 Sep; 17(9):769-771. PubMed ID: 30092691
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice.
    Li W; Ye L; Carrion R; Mohan GS; Nunneley J; Staples H; Ticer A; Patterson JL; Compans RW; Yang C
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S398-403. PubMed ID: 25877553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing reveals a controlled immune response to Zaire Ebola virus challenge in cynomolgus macaques immunized with vesicular stomatitis virus expressing Zaire Ebola virus glycoprotein (VSVΔG/EBOVgp).
    Barrenas F; Green RR; Thomas MJ; Law GL; Proll SC; Engelmann F; Messaoudi I; Marzi A; Feldmann H; Katze MG
    Clin Vaccine Immunol; 2015 Mar; 22(3):354-6. PubMed ID: 25589554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.